IRON AMINOS PT-141 10MG
Research-grade melanocortin-pathway peptide prepared for consistency and clear documentation in professional lab workflows.
Key Features
-
10mg PT-141 per vial (lyophilized powder)
-
≥99% purity for reproducible results
-
Sterile, sealed glass vial with tamper-evident flip cap
-
Lot/batch labeling for traceability
-
Signature Iron Aminos red-honeycomb label for quick identification
-
Diluent not included
Specifications
-
Compound: PT-141 (bremelanotide)
-
Class/Targets: Melanocortin receptor agonist (primarily MC4R/MC3R)
-
Form/Appearance: Lyophilized powder, white to off-white
-
Amount: 10mg per vial • Purity: ≥99%
-
Storage (lyophilized): Cool, dry, protected from light
-
Storage (after reconstitution): Refrigerate; use promptly per internal SOP
What’s Included
-
1 × PT-141 10mg vial (no diluent)
Handling
Reconstitute with an appropriate sterile diluent using aseptic technique. Follow your lab’s SOPs for aliquoting, labeling, and disposal.
Research Snapshot
-
Melanocortin receptor agonism (MC4R/MC3R) has been studied for modulation of central arousal pathwaysand related neuroendocrine signaling in preclinical and clinical research.
-
Human studies with bremelanotide formulations have reported improvements in validated sexual-function endpoints in specific populations; a formulation is FDA-approved for acquired, generalized HSDD in premenopausal women (class labeling notes nausea/flushing among common AEs).
-
Transient blood pressure increases and heart-rate decreases have been observed post-dose in some protocols; study designs often include dose titration and cardiovascular monitoring.
-
Outcomes are model- and protocol-dependent; compound supplied here is investigational for laboratory use only.
Compliance
For research use only. Not for human consumption.
Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.
